Biotechnology drugs and managed care for
โ
Alice M. Sapienza; Christine Cassell; Marie Bullock
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 95 KB
This article describes the results of a survey of formulary managers regarding policies and practices relevant to biotechnology medicines. The objectives of the survey were to 1) classify major strategies for controlling current expenditures on biotechnology drugs within managed care plans, 2) categ